Additionally, PTBP3 overexpression was found in hepatocellular cancer [7], gastric cancer [8], and breast cancer [6] and was correlated with a poor clinical prognosis, suggesting that PTBP3 may serve as an oncogene in multiple cancers. This evidence concerns the gene PTBP3 and breast carcinoma.